Palmoplantar pustulosis: A clinical and immunohistological study

British Journal of Dermatology

Volumn 138, Issue 3, 1998, Pages 390-398

  Eriksson, M O ^a   Hagforsen, E ^a   Lundin, I P ^a   Michaelsson G ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; GLIADIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; PROTIRELIN; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE; THYROXINE;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CELIAC DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL; FEMALE; HUMAN; HUMAN TISSUE; MALE; MAST CELL; NEUTROPHIL; PRIORITY JOURNAL; PUSTULOSIS PALMOPLANTARIS; SKIN BIOPSY; SKIN INFLAMMATION; SMOKING; T LYMPHOCYTE; THYROID DISEASE;

ADULT; AGED; ANTIGENS, CD3; BIOPSY; FEMALE; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MAST CELLS; MIDDLE AGED; NEUTROPHILS; PARAFFIN EMBEDDING; PSORIASIS; SWEAT GLANDS; T-LYMPHOCYTE SUBSETS; THYROID DISEASES;

EID: 0031919782     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02113.x     Document Type: Article

References (25)

1. Rosén K. Pustulosis palmo-plantaris and chronic hand dermatitis. Treatment, epidermal Langerhans cells and association with thyroid disease. Acta Denn Venereol (Stockh) 1988; 137 Supple: 1-52.
2. Akiyama T, Seishima M, Watanabe H, Nakatani A et al. The relationships of onset and exacerbation of pustulosis palmaris et plantaris to smoking and focal infections. J Dermatol 1995; 22: 930-4.
3. Kubeyinje EP, Belagavi CS, Risk factors for palmo-plantar pustulosis in a developing country. East Afr Med J 1997; 74: 54-5.
4. Lundin Å, Håkansson L, Michaëlsson G, Venge P, Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmo-plantaris compared with psoriasis. Arch Dermatol Res 1987; 279: 385-91.
5. Lundin Å, Fredens K, Michaëlsson G, Venge P. The eosinophil granulocyte in psoriasis. Br J Dermatol 1990; 122: 181-93.
6. Michaëlsson G, Kraaz W, Gerdén B et al. Patients with psoriasis often have increased serum levels of IgA antibodies to gliadin. Br J Dermatol 1993; 129: 667-73.
7. Michaëlsson G, Kraaz W, Gerdén B et al. Patients with psoriasis have elevated levels of serum eosinophil cationic protein and increased numbers of EG2 positive eosinophils in the duodenal stroma. Br J Dermatol 1996; 135: 371-8.
8. Axelsson L, Bergenfeldt M, Ohlsson K. Studies of the release and turnover of a human neutrophil lipocalin. Scand J Clin Lab Invest 1995; 55: 577-88.
9. Michaëlsson G, Kraaz W, Hagforsen E et al. Psoriasis patients have highly increased numbers of tryptase-positive mast cells in the duodenal stroma. Br J Dermatol 1997; 136: 866-70.
10. Watanabe S, Ichikawa E, Takanashi S, Takanashi H. Immunohistochemical localization of cytokeratins in normal eccrine glands, with monoclonal antibodies in routinely processed, formalin-fixed, paraffin-embedded sections. J Am Acad Dermatol 1993; 28: 203-12.
11. Uhehara M, Ofuji S. The morphogenesis of pustulosis palmaris et plantaris. Arch Dermatol 1974; 109: 518-20.
12. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045-9.
13. Burrows LJ, Piper PJ, Lindley ID, Westwick J. Intraperitoneal injection of human recombinant neutrophil-activating factor/ interleukin 8 produces a T cell and eosinophil infiltrate in the guinea pig lung. Effect of PAF antagonist WEB 2086. Ann NY Acad Sci 1991; 629: 422-4.
14. Anttila Heli SI, Reitamo S, Erkko P et al. Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis. J Invest Dermatol 1992; 98: 96-101.
15. Moller A, Lippert U, Lessman D et al. Human mast cells produce IL-8. J Immunol 1993; 15: 3261-6.
16. Cox A. Mast cells in psoriasis. In Psoriasis. Proceedings of the Second International Symposium, 1976 (Farber E, Cox A, eds). New York: Yorke Medical Books, 1977; 36-43.
17. Kutzner H, Wurzel RM, Wolff HH. Are acrosyringia involved in the pathogenesis of 'dyshidrosis'? Am J Dermatopathol 1986; 8:109-16.
18. Wollina U, Schaarschmidt H, Knopf B, Hipler C. Keratinozyten des Acrosyringium-keine Differenzierungsstörung bei Psoriasis vulgaris. Dermatol Monatsschr 1990; 176: 151-5.
19. Juhlin L. Effect of treatment on sweat retention in psoriasis. Acta Derm Venereol 1967; 47: 98-101.
20. Johnson C, Shuster S. Eccrine sweating in psoriasis. Br J Dermatol 1969; 81: 119-24.
21. Mcgregor AM. The thyroid gland and disorders of thyroid function. In: Oxford Textbook of Medicine (Weatherall DJ, Ledingham JGG, Warrell DA eds). Oxford: Oxford University Press, 1996; 1603-18.
22. Tomic-Canic M, Day D, Samuels H et al. Novel regulation of keratin gene expression by thyroid hormone and retinoid receptors. J Biol Chem 1996; 271: 1416-23.
23. Michaëlsson G, Kraaz W, Hagforsen E et al. Increased lymphocyte infiltration in duodenal mucosa from patients with psoriasis and serum IgA antibodies to gliadin. Br J Dermatol 1995; 133: 896-904.
24. Theilig C, Bernd D, Ramirez-Bosca A et al. Reactions of human keratinocytes in vitro after application of nicotine. Skin Pharmacol 1994; 6: 307-15.
25. Grando SA, Horton RM. Pereira EF et al. A nicotinic acetylcholine receptor regulating cell adhesion and motility is expressed in human keratinocytes. J Invest Dermatol 1995; 105: 774-81.